Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Padmapriyadarsini

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|November 1, 2021
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine ResponsesNathella Pavan Kumar, V V Banurekha, Girish Kumar C P, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus diseasePrema Gurumurthy, Geetha Ramachandran, A K Hemanth Kumar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic settingK S Sachdeva, A K Bhatnagar, A Bhaskar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2010
Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional studyS Swaminathan, C Padmapriyadarsini, L Yoojin, et al.
The Pediatric Infectious Disease Journal|December 1, 2017
High Prevalence of Lipid Abnormalities and Insulin Resistance Among Antiretroviral Naïve HIV-infected Children in IndiaC Padmapriyadarsini, Anita Shet, R Srinivasan, et al.
Global Health Research and Policy|May 19, 2022
Experience on the first national anti-TB drug resistance survey (DRS) in Timor-LesteConstantino Lopes, Debashish Kundu, Ismael Da Costa Barreto, et al.
The Indian Journal of Medical Research|September 16, 2021
Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot studyNathella Pavan Kumar, C Padmapriyadarsini, K R Uma Devi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Establishing proof of concept for utility of Trueprep<sup>®</sup>-extracted DNA in line-probe assay testingP Rajendran, S Saini, N Kumar, et al.
The Indian Journal of Medical Research|June 19, 2021
Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme settingC Padmapriyadarsini, L Sekar, Devarajulu Reddy, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|November 1, 2021
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine ResponsesNathella Pavan Kumar, V V Banurekha, Girish Kumar C P, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus diseasePrema Gurumurthy, Geetha Ramachandran, A K Hemanth Kumar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic settingK S Sachdeva, A K Bhatnagar, A Bhaskar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2010
Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional studyS Swaminathan, C Padmapriyadarsini, L Yoojin, et al.
The Pediatric Infectious Disease Journal|December 1, 2017
High Prevalence of Lipid Abnormalities and Insulin Resistance Among Antiretroviral Naïve HIV-infected Children in IndiaC Padmapriyadarsini, Anita Shet, R Srinivasan, et al.
Global Health Research and Policy|May 19, 2022
Experience on the first national anti-TB drug resistance survey (DRS) in Timor-LesteConstantino Lopes, Debashish Kundu, Ismael Da Costa Barreto, et al.
The Indian Journal of Medical Research|September 16, 2021
Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot studyNathella Pavan Kumar, C Padmapriyadarsini, K R Uma Devi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Establishing proof of concept for utility of Trueprep<sup>®</sup>-extracted DNA in line-probe assay testingP Rajendran, S Saini, N Kumar, et al.
The Indian Journal of Medical Research|June 19, 2021
Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme settingC Padmapriyadarsini, L Sekar, Devarajulu Reddy, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 6